Choreographing Your Financings

05 May 2015 01:45 p.m. - 03:50 p.m.

Tel Aviv Hilton Hotel
205 Hayarkon Street
Independence Park
Tel Aviv, 6340506
Harrison Lawrence
(212) 336-4004

For intellectual property-based companies, like technology and life science companies, planning your financing strategy is essential. Timing your financings in light of upcoming product announcements or design wins, milestones, or trial results may often be the difference between success and failure. In this complimentary series of sessions, Morrison & Foerster partners and guest speakers will focus on the special disclosure considerations and financing approaches that are most significant whether you are planning an IPO or are already a public company.


2:15 p.m. to 2:45 p.m.
Preparing for an IPO for the IP-Based Issuer

  • Discussion of IP risks
  • Disclosure relating to potential IP litigation arising around time of IPO
  • IP opinions

2:45 p.m. to 3:15 p.m.
Ongoing Disclosure Issues for IP-Based Companies

  • Milestones, royalties and your MD&A disclosure
  • Frequently Issued SEC comments
  • Obtaining confidential treatment

3:30 p.m. to 4:00 p.m. 
Financing Trends for Tech and Biotech Companies

  • The Pre-IPO private placement
  • Equity Lines, PIPEs and Confidentially Marketed Public Offerings
  • Sequencing Financings in Conjunction with Clinical and Related Announcements



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.